The Scientific Advancements That Brought Us Non-surgical Facelifts

Non-surgical facelifts, also known as “liquid facelifts,” are a popular cosmetic procedure aiming to rejuvenate the face using injectable fillers and neuromodulators. They offer a less invasive alternative to traditional facelifts, such as mini facelift, which involves surgically cutting and repositioning the skin.

But how did non-surgical facelifts come into the limelight? Here are five scientific advancements that made non-surgical facelifts possible. Let’s get right to it.

1.   The Development of Hyaluronic Acid Fillers

The use of injectable fillers for facial rejuvenation dates back to the early 20th century when paraffin was first injected into the face. However, it wasn’t until the development of hyaluronic acid fillers in the 1980s that non-surgical facelifts began to gain widespread popularity. Hyaluronic acid is a naturally occurring substance in the body that helps to plump and hydrate the skin. When injected into the face, it can smooth out wrinkles and add volume to areas such as the cheeks and lips.

2.   The Introduction of Neuromodulators

The introduction of neuromodulators, such as Botox and Dysport, in the 1990s revolutionized the field of non-surgical facelifts. These products temporarily paralyze the muscles that cause wrinkles, leading to a smoother, more youthful appearance. They are most commonly used to treat wrinkles caused by repetitive facial expressions, such as frown lines and crow’s feet.

3.   The Development of Targeted Filler Products

One recent advancement in the field of non-surgical facelifts is the development of new filler products specifically formulated to target specific areas of the face. For example, Sculptra is a filler that stimulates the production of collagen, a protein that gives skin its structure and elasticity. It is often used to treat deeper wrinkles and add midface volume. Another example is Belotero, a filler made from a highly cohesive gel specifically designed to fill fine lines and wrinkles around the mouth and nose.

4.   Improved Injection Techniques

Another significant advancement is the development of more precise injection techniques. In the past, injectables were often placed too superficially, leading to a less natural-looking result. Today, doctors have a better understanding of the anatomy of the face. They can use techniques such as microdroplet injection and mini facelifts to achieve a more subtle and natural-looking result.

5.   Advanced Technologies and Tools

Significant improvements have been made in the tools and technologies used for non-surgical facelifts. For example, ultrasound and other imaging techniques have allowed doctors to visualize the underlying tissues and muscles better, leading to more precise and accurate injections. In addition, using numbing agents and other pain management techniques has made non-surgical facelifts much more comfortable for patients.

Conclusion

Scientific advancements in facial rejuvenation have brought us non-surgical facelifts, which have become a popular and effective way for patients to rejuvenate their appearance without surgery and the associated scars. Despite these advancements, non-surgical facelifts are no substitute for traditional or mini facelifts. They are best suited for patients with mild to moderate fa

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”